Immune to Cancer: The CRI Blog
-
Exploring the Potential of Natural Killer Cells with Dr. Oscar Aguilar
CRI postdoctoral fellow Dr. Oscar Aguilar is exploring the biology of Natural Killer cells in order to…
-
The Microbiome and Cancer-on-a-Chip with Dr. Hyun Jung Kim
CRI Tech Impact grantee Dr. Hyun Jung Kim is building a colorectal-cancer-on-a-chip device to better understand how…
-
CRI Celebrates a Future #Immune2Cancer on June 12
On Friday, June 12, 2020, the global cancer community joined the Cancer Research Institute’s annual awareness day to amplify the lifesaving potential…
-
A Special Message from the Cancer Research Institute
CRI joins people within science, technology, engineering, and mathematics to pause our work as part of #ShutDownSTEM to…
-
Recapping ASCO20: The Next Horizons in Immunotherapy
The 56th Annual ASCO Meeting highlighted advances in checkpoint immunotherapy, cell-based immunotherapies, and bispecific antibodies.
-
ASCO20 Update: Considerations for Checkpoint Inhibitors Moving Forward
Results unveiled at ASCO20 increased our understanding of checkpoint immunotherapy in a variety of cancers and circumstances.
-
ASCO20 Update: Cellular Immunotherapies, Genomics, and COVID-19
Several promising cellular immunotherapies were discussed at ASCO20, including those for solid cancers; plus updates on the cancer…
-
Investigating the Innate Immune Receptor NLRP6 with Dr. Chen Shen
CRI Fellow Dr. Chen Shen is investigating NLRP6, a receptor that can recognize bacteria or viruses and…
-
Building a Single-Cell Atlas with Dr. Ansuman Satpathy
Dr. Ansuman Satpathy is building a single-cell atlas to help us better understand why immunotherapy succeeds or…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.